Researchers discover new molecular target that could treat idiopathic pulmonary fibrosis
Researchers at the University of Alabama at Birmingham have identified a new molecular target that could potentially treat the deadly, […]
(HealthDay)—A new drug to treat most cystic fibrosis patients has been approved by the U.S. Food and Drug Administration. Trikafta […]fibrosis
FDA approves new drug for most common form of cystic fibrosis